Systems and methods for treating dermatological imperfections

1. A method for non-injurying heat shock stimulation of human or animal tissue comprising:

positioning a distal end of a handheld dermatological medical device at a region proximal a target therapeutic region of tissue;

outputting optical energy from an optical laser of the handheld dermatological medical device at the target therapeutic region of tissue; and

controlling the output of the optical energy at the target therapeutic region of tissue to increase a temperature of the target therapeutic region of tissue for a period of time to a temperature range that is less than an injurying temperature and induces an expression of heat shock proteins (HSPs) at the target therapeutic region of tissue, by outputting the optical energy at an initial power density of a maximum of 400 W/cm 2 for a minimum time of 20 ms required to increase the temperature of the target therapeutic region of tissue during an initial optical laser treatment time period between 2-8 degrees C. until the temperature of the target therapeutic region of tissue is at the temperature range that induces the expression of HSPs and is less than the injurying temperature followed by a subsequent optical laser treatment time period during which the initial power density of the optical energy is automatically reduced to have an average power density less than the initial power density which maintains the temperature of the target therapeutic region of tissue at the temperature range that induces that expression of HSPs and is less than the injurying temperature; and further controlling one or more power levels of the optical energy according to an optical power temperature profile to provide a power density during the subsequent optical treatment time period substantially less than the initial power density and as low as 0.1 W/cm 2 for maintaining, during the subsequent optical laser treatment time period, the temperature of the target therapeutic region of tissue to be less than the injurying temperature at an optical energy exposure time at a wavelength between 1400-1530 nm that provides a thermal exposure time for maintaining the temperature increase at the target therapeutic region of tissue.

2. The method of claim 1 , wherein controlling the output of optical energy includes outputting the optical energy to have at least one of a wavelength, energy dosage, or thermal boost that provides a non-injurying heat shock stimulation at the therapeutic region of tissue depending on the optical properties of the skin and its wavelength.

3. The method of claim 1 , further comprising modifying a spatial distribution of the optical energy to a desired distribution at a distal end of the handheld dermatological medical device.

4. The method of claim 1 , further comprising controlling a temporal profile of energy delivered to the target therapeutic region of tissue.

5. The method of claim 1 , wherein an exposure of energy output from the dermatological medical device at the target therapeutic region of tissue is between 2-10 seconds at one or more temperatures less than the injurying temperature.

6. The method of claim 1 , further comprising controlling a temperature temporal profile of the target therapeutic tissue by modulating the temporal profile of an energy source of the optical energy.

7. The method of claim 1 , further comprising controlling a therapeutic energy dosage by controlling the temporal profile of the optical energy, and wherein peak powers and exposure time are modulated to provide a desired clinical effect.

8. A method for non-injurying heat shock stimulation of human or animal tissue comprising:

providing a handheld treatment device with a distal treatment end; and

outputting optical energy from an optical laser of the handheld treatment device at a target therapeutic region of tissue, wherein a treatment provides a heat shock protein expression, including outputting the optical energy at an initial power density having a maximum of 400 W/cm 2 for a minimum time of 20 ms required to increase a temperature of the target therapeutic region of tissue during an initial optical laser treatment time period between 2-8 degrees C. until the temperature of the target therapeutic region of tissue is at a temperature range that induces an expression of HSPs and is less than an injurying temperature followed by a subsequent optical laser treatment time period during which the power density of the optical energy is reduced to have an average power density less than the initial power density which maintains the temperature range that induces that expression of HSPs and during which the temperature of the target therapeutic region of tissue is less than the injurying temperature, wherein a total laser treatment time that includes the initial optical laser treatment time period and the subsequent optical laser treatment time period is less than 10 seconds; and further controlling one or more power levels of the optical energy according to an optical power temporal profile to provide a power density during the subsequent optical treatment time period substantially less than the initial power density and as low as 0.1 W/cm 2 for maintaining, during the subsequent optical laser treatment time period, the temperature of the target therapeutic region of tissue to be less than the injurying temperature at an optical energy exposure time at a wavelength between 1400-1530 nm that provides a thermal exposure time for maintaining the temperature increase at the target therapeutic region of tissue.

9. The method of claim 8 , wherein a peak of the expression of HSPs occur 1.5 hours to 48 hours after the treatment.

10. A method for non-injurying heat shock stimulation of human or animal tissue comprising:

providing a handheld treatment member with a distal treatment end; and

outputting optical energy from the distal treatment end of the handheld treatment member at a target therapeutic region of tissue, wherein the outer surface of the target therapeutic region of tissue is removed of energy absorbing chromophore prior to an optical energy treatment, wherein the optical energy is output at an initial power density a maximum of 400 W/cm 2 for a minimum time of 20 ms required to increase the temperature of the target therapeutic region of tissue during an initial optical laser treatment time period between 2-8 degrees C. until the temperature of the target therapeutic region of tissue is at the temperature range that induces the expression of HSPs and is less than an injurying temperature followed by a subsequent optical laser treatment time period during which the initial power density of the optical energy is reduced to have an average power density less than the initial power density which maintains the temperature range that induces that expression of HSPs and during which the temperature of the target therapeutic region of tissue is less than the injurying temperature, wherein a total laser treatment time that includes the initial optical laser treatment time period and the subsequent optical laser treatment time period is less than 10 seconds; and

further controlling one or more power levels of the optical energy according to an optical power temporal profile to provide a power density during the subsequent optical treatment time period substantially less than the initial power density and as low as 0.1 W/cm 2 for maintaining, during the subsequent optical laser treatment time period, the temperature of the target therapeutic region of tissue to be less than the injurying temperature at an optical energy exposure time at a wavelength between 1400-1530 nm that provides a thermal exposure time for maintaining the temperature increase at the target therapeutic region of tissue.

11. The method of claim 10 , wherein a water chromophore is reduced from the stratum corneum through an aqueous dessecating solution.

12. The method of claim 10 , wherein an application of the handheld treatment member is selected from the group consisting of: wrinkle reduction; acne reduction; skin tightening; tissue heating; treatment of fibrous tissue; treatment of vascular tissue; and combinations thereof.